MANAGEMENT OF CARDIAC ARRHYTHMIAS
Before initiating antiarrhythmic therapy, one must determine whether the arrhythmia should be treated. Any arrhythmia that causes symptomatic hypotension or sudden death should be supÂpressed. However, the situation in which the arÂrhythmia occurs dictates whether chronic, long-term therapy is necessary. For example, an epiÂsode of ventricular fibrillation in a patient at the onset of an acute myocardial infarction does not necessarily require long-term drug therapy beÂcause of the low likelihood of recurrence.
HowÂever, ventricular fibrillation in a patient without an acute myocardial infarction carries a high risk of recurrence. Some patients may have arrhythÂmias that, while not life-threatening, produce disÂabling symptoms of dizziness or palpitations and require therapy. Rhythms that are tolerated well in patients with structurally normal hearts (for exÂample, paroxysms of supraventricular tachycarÂdia) may not be tolerated in patients with diseased hearts (for example, ischemic heart disease or miÂtral stenosis) and may require therapy. The deÂcision to treat a patient with an asymptomatic tachyarrhythmia is more difficult. Certain arÂrhythmias, such as short episodes of asymptoÂmatic nonsustained ventricular tachycardia, are in themselves harmless but may be forerunners of more serious sustained ventricular tachyarrhythÂmias. The decision to treat is complicated by the side effects, occasionally life-threatening, of anÂtiarrhythmic drugs, such as exacerbation of ventricular arrhythmias in 5 to 15 per cent of cases. Even though patients with premature ventricular complexes and complex ventricular ectopy after myocardial infarction are at increased risk of subÂsequent sudden death, it is not clear that antiarÂrhythmic treatment reduces the increased morÂtality.
Before beginning chronic antiarrhythmic therÂapy, factors contributing to the occurrence of the arrhythmia should be considered. These include digitalis excess, hypokalemia, Hypomagnesemia, hypoxia, thyrotoxicosis, and other severe metaÂbolic derangements. Congestive heart failure, aneÂmia, or infection should be corrected. Smoking, excessive alcohol intake, caffeine- or theophyl-line-containing beverages or foods, fatigue, emoÂtional upset, and some over-the-counter drugs (for example, nasal decongestants) may exacerbate arÂrhythmias.
- MULTIVALVULAR DISEASE
- MANAGEMENT OF CARDIAC ARRHYTHMIAS
- COMPLICATIONS OF MYOCARDIAL INFARCTION AND THEIR MANAGEMENT
- PULMONARY HEART DISEASE
- PATHOPHYSIOLOGY OF ISCHEMIC HEART DISEASE
- ANGINA PECTORIS
- NONOBSTRUCTIVE CAUSES OF ISCHEMIC HEART DISEASE
- RISK FACTORS
- MECHANISMS OF ARRHYTHMOGENESIS
- RHEUMATIC FEVER
- APPROACH TO THE PATIENT WITH SUSPECTED OR CONFIRMED ARRHYTHMIAS
- MEDICAL MANAGEMENT OF ANGINA
- GENERAL MANAGEMENT OF MYOCARDIAL INFARCTION
- ATHEROSCLEROSIS
- VARIATiT ANGINA
- NONMEDICAL MANAGEMENT OF ANGINA PECTORIS
- NONATHEROSCLEROTIC CAUSES OF CORONARY ARTERY OBSTRUCTION
- PROSTHETIC VALVES
- ARRHYTHMIAS in ACUTE MYOCARDIAL MFARCTION
- CLINICAL PRESENTATION
- ACUTE MYOCARDIAL INFARCTION
- LIMITATION OF MFARCT SIZE